TERF2 and ORC6

  • Number of citations of the paper that reports this interaction (PMID 18761675)
  • 15

TERF2

ORC6

Gene Name telomeric repeat binding factor 2 origin recognition complex, subunit 6
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 55 interactors: AFAP1L2 ANXA5 APEX1 ASS1 ATM BANP BLM CCDC137 CTBP1 DCLRE1B DDX21 DDX24 DDX39A EP300 GNMT H2AFX HDGFRP2 HEXIM1 HEXIM2 HMGB1 HMGN1 HMGN2 HMGN3 HMGN4 LANCL2 LYAR MAGOHB NAIF1 NASP NCL NUMA1 NXNL1 OCM2 ORC3 ORC6 POT1 PPM1G PRMT1 PTMA RNF113A RPL13 RPRD1B SET SIAH1 SP100 SRSF6 TALDO1 TERF2IP TINF2 TMSB10 TOR1AIP1 WDR4 WRN XRCC6 ZC3H18 19 interactors: APP CDC45 CDC6 CDC7 DBF4 HMGA1 LHX4 MCM2 MCM4 MCM5 MCM6 MCM7 ORC2 ORC3 ORC4 ORC5 RPA1 SPAG5 TERF2
Entrez ID 7014 23594
HPRD ID 03610 06237
Ensembl ID ENSG00000132604 ENSG00000091651
Uniprot IDs Q15554 Q9Y5N6
PDB IDs 1H6P 1VF9 1VFC 1W0U 1XG1 3BU8 3BUA 3K6G 3SJM 4M7C 3M03
Enriched GO Terms of Interacting Partners?
Tagcloud ?
anticancer  catalytic  cloned  compensate  division  elucidated  encoding  erosion  fusions  generally  homolog  immortality  length  neoplasms  p80  protection  repeat  repeats  repressed  ribonucleoprotein  telomerase  telomere  telomeric  tep1  terc  terf1  tert  upregulated  withdrawal 
1br3htert  bjhtert  cdc6  codepletion  collectively  deplete  depletion  diminished  dormant  dramatically  exploited  h202  hydroxyurea  hypersensitivity  hypersensitized  licensed  licensing  maximally  modestly  nontumor  oncogene  optimally  orc1  origin  origins  overexpress  reliance  sensitize  viability 
Tagcloud (Difference) ?
anticancer  catalytic  cloned  compensate  division  elucidated  encoding  erosion  fusions  generally  homolog  immortality  length  neoplasms  p80  protection  repeat  repeats  repressed  ribonucleoprotein  telomerase  telomere  telomeric  tep1  terc  terf1  tert  upregulated  withdrawal 
1br3htert  bjhtert  cdc6  codepletion  collectively  deplete  depletion  diminished  dormant  dramatically  exploited  h202  hydroxyurea  hypersensitivity  hypersensitized  licensed  licensing  maximally  modestly  nontumor  oncogene  optimally  orc1  origin  origins  overexpress  reliance  sensitize  viability 
Tagcloud (Intersection) ?